SlideShare une entreprise Scribd logo
1  sur  40
Télécharger pour lire hors ligne
Ahmed Ezzat Fadl
Resident of Nephrology
(D.M.N.I)
1. DEFENITION
2. History of Renal biopsy
3. Indications
4. C.I
5. Preparation for biopsy
6. Procedure
7. Post procedure
8. Complications
Definition:-
 A renal biopsy is a procedure used to obtain a segment
of renal tissue, usually through a needle or another
surgical instrument.
History:-
 Before 1951, the only way of obtaining kidney tissue
from a live person was through an open operation.
 Danish physicians Poul Iversen and Claus Brun
described a method involving needle biopsy which has
become the new standard.
 Recent widespread availability of real-time imaging
guidance using ultrasound or CT scanning having
improved safety of the procedure.
Is the Biopsy Necessary?
 Always judge the balance of risk vs benefit
 Most nephrologists would agree that renal biopsy is
more likely to change management in symptomatic
kidney disease
 It can also be useful for prognostic purposes, as well as
helping to direct or change treatment
Indications
1) Significant proteinuria (>1g/day)/Nephrotic
syndrome with two normal sized, non-
obstructed, kidneys and no obvious cause (usually
considering the diagnosis of a glomerulo- or
interstitial nephritis)
2) Acute Kidney Injury (AKI) with two normal
sized, non-obstructed, kidneys and no obvious cause
(pre and post-renal causes excluded)or non resolving
clinical ATN>3-4 weeks
3) Chronic Kidney Disease (CKD) with two normal
sized, non-obstructed, kidneys and no obvious cause
4) Renal transplant dysfunction
5) Systemic disease with renal dysfunction
Less common (and more controversial) indications.
(Many of these patients may have normal renal function)
 Microscopic haematuria
 Familial renal disease (where
diagnosis in this patient, benefits
them and their family)
Diabetes and Renal Biopsy
 If the clinical presentation is consistent with diabetic
nephropathy
(ie ,signficant proteinuria [often nephrotic range], CKD3b-
4, diabetes of over 10 years duration, presence of other
microvascular complications [eg retinopathy and neuropathy])
biopsy is not necessary and it can be assumed that the patient has
diabetic nephropathy
(THE NEW TERM DKD) why!
 When to biopsy diabetic patient :
1) Microscopic hematuria
2) Absence of retinopathy and neuropathy
3) Onset of significant proteinuria <5 years from diagnosis
4) Acute worsening of renal function
5) Systemic features
 Pediatric age group:
 Sedation is used (ketamine, midazolam, promethazine, BZDs)
 18-G gun is used
 Pregnancy: Indications of biopsy
 Sudden unexplained deterioration of renal function before 30-32 weeks
POG
 Symptomatic N.S before 30-32 weeks POG
 Active urinary sediments, proteinuria and borderline renal function
renal biopsy in pregnancy is safe before 30
weeks of pregnancy.
Transplanted kidney
 Biopsy is performed from the transplanted kidney to
exclude rejection, BK nephropathy, drug-toxicity or
recurrence of the disease that caused kidney failure
 For surveillance of hidden disease involving the
transplant kidney, so-called protocol renal biopsy
undertaken at fixed intervals post-transplantation.
Age, Race and Renal Biopsy
 Moutzouris (2009) has published a series of biopsies
in the elderly (> 80 years) suggesting that this is still a
useful technique with results that affect management
in a significant number of patients.
 There are racial differences between biopsy
appearances.
For example, Hoy (2012) has described a wide range of
atypical findings in Australian aborginal people.
Contraindications
•6
Absolute
•3
Relative
1) Uncorrectable bleeding diathesis
2) Uncontrollable severe hypertension (>160/95)
3) Active renal or perirenal infection
4) Skin infection at biopsy site
5) Presence of a solitary native kidney(except in …… )
6) Renal neoplasm, multiple cysts, abscess or pyelonephritis
1) Certain anatomical abnormalities of the kidney (eg
vascular lesion)
2) Medications that interfere with clotting (e.g.
warfarin or heparin)
3) Pregnancy(safe before 30 w)
4) Uncooperative patient (some consider absolute C.I)
Prior to the procedure
 Informed consent is usually taken.
 Arrangements will also be made to ensure that
appropriate post-biopsy care and supervision is in
place
 The patient has the right to consent or decline
Before biopsy
 NSAIDs should be stopped 24 hours before procedure.
 For elective biopsies, anti-platelet agents (aspirin &clopidogrel)
should be stopped 7 days before the biopsy.
 Warfarin should ideally be stopped 7 days before the procedure
and the patient converted to heparin if clinically indicated.
 Heparin (including prophylactic and LMW) should be stopped at
least 24 hours pre-procedure.
 Ideally anticoagulation should not be restarted for 1 week post-
biopsy.
 If clinically indicated anticoagulation can be started after 24
hours, but this should be delayed further if there is macroscopic
haematuria or a drop in haemoglobin.
Biopsy gun :
 14 G guns gives greater number of glomeruli per core
than 18-G cores, but the rates of adequate biopsies
were similar
 Larger needle provided more tissue and glomeruli but
were associated with more pain.
 16-gauge needles are used as a compromise between
the need of a sufficient size of tissue and the need of
clinical safety.
 Biopsy sample is divided and sent off for:
light microscopy , Immunoflourescence and Electron
microscopy
Procedure
 Patient in prone position with wedge or pillow below the abdomen
 Light sedation
 Local anesthesia with 1-2% lignocaine subcutaneous
 Stab incision can be given to ease biopsy gun entry
 Advance the biopsy gun, when the capsule is reached, instruct patient
to take a deep breath and fire the gun
 2-3 cores can be taken from the lower pole of the left kidney & placed
in 10ml of normal saline 0.9% and taken to the laboratory.
 Press on wound for 2-5 minutes
 Renal biopsy is typically performed by a
nephrologist or interventional radiologist
Post procedure
 Bed rest flat on back(≈4 hr) is instructed
 BP and pulse are monitored in the following way:-
Every 15 mins for 1 hour
Every 30 mins for 1 hour
Every hour for 4 hours
 4 hourly for next remaining 24 hours
 Save each voided urine sample in clear specimen
container
 CBC & Hct monitored 6-8 hours and 18-24 hours after
biopsy
omplicationsC
1) Bleeding
2) AV fistula - these are common and can be demonstrated
by angiography in 10-20% of patients. Such lesions are
usually clinically silent, and more than 95% resolve
spontaneously within 2 years. In rare
instances, embolisation or surgical correction of the
fistula is required because of severe
hypertension, persistent hematuria, congestive heart
failure, or hydronephrosis
3) Aneurysm - these occur in less than 1% of patients and
the majority resolve spontaneously Rarely they can lead to
significant ischaemic problems and may require
omplicationsCCont.
4) Biopsy of other organs (spleen, liver, pancreas, bowel,
gall bladder)
5) Calyceal-peritoneal fistula
6) Dispersion of carcinoma
7) 'Page kidney' - compression of the kidney by peri-renal
haematoma leading to renin-mediated hypertension
There is also an approximately 5% chance of obtaining an
inadequate tissue sample.
In other words, from the patients' perspective, the most
important common complication of biopsy is
having to do it agaaaaaain  
Haemorrhage
The major complication of renal biopsy is bleeding. A
degree of peri-renal bleeding post-biopsy is inevitable
and the mean fall in haemoglobin after a renal biopsy is 1
g/dL
 Bleeds are usually small and self-limiting and manifest as:
 Peri-renal haematoma (Manno, 2004).
Peri-renal haematomas are common, and usually self
limiting..
 Non-visible haematuria (35%).
 Visible haematuria (3%).
of a major bleedanagementM
 Tachycardia may be the first sign of bleeding – take it seriously
 Classic signs of shock and back pain may happen much later
 If shock develops call your blood bank and X-match 2 (or more) units
of blood
 Ensure the patient has good (wide bore) IV access, replace volume
loss with IV saline/colloid in the first instance
 Arrange an urgent ultrasound to see if there is any bleed around the
kidney (peri-renal haematoma). A CT angiogram can be useful to
identify both a peri-renal haematoma and also the presence and site of
active bleeding
 Occassionally heavy haematuria may cause clot colic or acute urinary
retention
 Prolonged or severe bleeding may require angiography and coil
embolisation. It is sensible to inform the urologists at this stage - if
angiography and embolisation fail to stop the bleeding.Nephrectomy
will be required
Discharge & follow up
 Warn the patient they will feel sore around the biopsy
site for 3-4 days. Patients should be given clear
(written) instructions regarding pain and haematuria
before they go home. These should include 24 hour
contact numbers in case of complications that arise
after discharge.
 All patients who have had a renal biopsy should be
seen in clinic soon after discharge:
 Transplant biopsy: 1-2 days
 Native biopsy: 2 weeks
Renal biopsy fadl
Renal biopsy fadl

Contenu connexe

Tendances

Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of HemodialysisMNDU net
 
Presentation: HCV in dialysis
Presentation: HCV in dialysisPresentation: HCV in dialysis
Presentation: HCV in dialysisdrsalwa22000
 
Hepatitis B in Dialysis and Transplantation
Hepatitis B in Dialysis and TransplantationHepatitis B in Dialysis and Transplantation
Hepatitis B in Dialysis and TransplantationSandeep Gopinath Huilgol
 
Renal biopsy, nadia
Renal biopsy, nadiaRenal biopsy, nadia
Renal biopsy, nadiaFarragBahbah
 
Interpretation of renal biopsy
Interpretation of renal biopsyInterpretation of renal biopsy
Interpretation of renal biopsyBiswajeeta Saha
 
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysisAdequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysisIPMS- KMU KPK PAKISTAN
 
Acute peritoneal dialysis prescription
Acute peritoneal dialysis prescriptionAcute peritoneal dialysis prescription
Acute peritoneal dialysis prescriptionIPMS- KMU KPK PAKISTAN
 
Vaccination in ckd patients
Vaccination in ckd patientsVaccination in ckd patients
Vaccination in ckd patientsApollo Hospitals
 
Obstructive Uropathy "online"
Obstructive Uropathy "online"Obstructive Uropathy "online"
Obstructive Uropathy "online"Ayman Rashed, MD
 
Basics of peritoneal dialysis
Basics of peritoneal dialysisBasics of peritoneal dialysis
Basics of peritoneal dialysisVishal Golay
 

Tendances (20)

Obstructive uropathy
Obstructive uropathyObstructive uropathy
Obstructive uropathy
 
Renal biopsy interpretation
Renal biopsy interpretationRenal biopsy interpretation
Renal biopsy interpretation
 
Sickle cell nephropathy SCN
Sickle cell nephropathy SCNSickle cell nephropathy SCN
Sickle cell nephropathy SCN
 
SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
 
Dialysate
DialysateDialysate
Dialysate
 
Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of Hemodialysis
 
Dialysis prescription
Dialysis prescriptionDialysis prescription
Dialysis prescription
 
Renal biopsy protocol
Renal biopsy protocolRenal biopsy protocol
Renal biopsy protocol
 
Presentation: HCV in dialysis
Presentation: HCV in dialysisPresentation: HCV in dialysis
Presentation: HCV in dialysis
 
Hepatitis B in Dialysis and Transplantation
Hepatitis B in Dialysis and TransplantationHepatitis B in Dialysis and Transplantation
Hepatitis B in Dialysis and Transplantation
 
Renal biopsy, nadia
Renal biopsy, nadiaRenal biopsy, nadia
Renal biopsy, nadia
 
Interpretation of renal biopsy
Interpretation of renal biopsyInterpretation of renal biopsy
Interpretation of renal biopsy
 
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysisAdequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
 
Acute peritoneal dialysis prescription
Acute peritoneal dialysis prescriptionAcute peritoneal dialysis prescription
Acute peritoneal dialysis prescription
 
Vaccination in ckd patients
Vaccination in ckd patientsVaccination in ckd patients
Vaccination in ckd patients
 
Obstructive Uropathy "online"
Obstructive Uropathy "online"Obstructive Uropathy "online"
Obstructive Uropathy "online"
 
Deceased donor kidney transplant
Deceased donor kidney transplantDeceased donor kidney transplant
Deceased donor kidney transplant
 
Nephrology lectures
Nephrology lecturesNephrology lectures
Nephrology lectures
 
Basics of peritoneal dialysis
Basics of peritoneal dialysisBasics of peritoneal dialysis
Basics of peritoneal dialysis
 
Dialyzable drugs
Dialyzable drugsDialyzable drugs
Dialyzable drugs
 

Similaire à Renal biopsy fadl

CLINICAL MEET IVC thrombosis.pptx
CLINICAL MEET IVC thrombosis.pptxCLINICAL MEET IVC thrombosis.pptx
CLINICAL MEET IVC thrombosis.pptxMehak783822
 
PCI complications
PCI complicationsPCI complications
PCI complicationsIqbal Dar
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantationSouvik Maitra
 
Early care kidney transplant
Early care kidney transplantEarly care kidney transplant
Early care kidney transplantMouhmad Qasem
 
APPROACH TO GASTROINTESINAL BLEEDING
APPROACH TO GASTROINTESINAL BLEEDINGAPPROACH TO GASTROINTESINAL BLEEDING
APPROACH TO GASTROINTESINAL BLEEDINGArkaprovo Roy
 
Adverse events in endoscopic interventions.pptx
Adverse events in endoscopic interventions.pptxAdverse events in endoscopic interventions.pptx
Adverse events in endoscopic interventions.pptxAnkit Anand
 
Renal Biopsy-WPS Office.ppt
Renal  Biopsy-WPS Office.pptRenal  Biopsy-WPS Office.ppt
Renal Biopsy-WPS Office.pptMohan Mandem
 
Management of penetrating renal injury
Management of penetrating renal injury Management of penetrating renal injury
Management of penetrating renal injury George Owusu
 
early care post kidney trasplantation .
early care post kidney trasplantation . early care post kidney trasplantation .
early care post kidney trasplantation . Mouhmad Qasem
 
Lower Gastrointestinal Bleeding
Lower Gastrointestinal BleedingLower Gastrointestinal Bleeding
Lower Gastrointestinal BleedingAfiqah Faizal
 
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....Gianfranco Tammaro
 

Similaire à Renal biopsy fadl (20)

Renal biopsy
Renal biopsyRenal biopsy
Renal biopsy
 
CLINICAL MEET IVC thrombosis.pptx
CLINICAL MEET IVC thrombosis.pptxCLINICAL MEET IVC thrombosis.pptx
CLINICAL MEET IVC thrombosis.pptx
 
PCI complications
PCI complicationsPCI complications
PCI complications
 
Renal biopsy
Renal biopsyRenal biopsy
Renal biopsy
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantation
 
Early care kidney transplant
Early care kidney transplantEarly care kidney transplant
Early care kidney transplant
 
APPROACH TO GASTROINTESINAL BLEEDING
APPROACH TO GASTROINTESINAL BLEEDINGAPPROACH TO GASTROINTESINAL BLEEDING
APPROACH TO GASTROINTESINAL BLEEDING
 
Liver biopsy
Liver biopsyLiver biopsy
Liver biopsy
 
CUT.docx
CUT.docxCUT.docx
CUT.docx
 
Adverse events in endoscopic interventions.pptx
Adverse events in endoscopic interventions.pptxAdverse events in endoscopic interventions.pptx
Adverse events in endoscopic interventions.pptx
 
Liver biopsy
Liver biopsyLiver biopsy
Liver biopsy
 
Chronic renal failure, surgical management
Chronic renal failure, surgical managementChronic renal failure, surgical management
Chronic renal failure, surgical management
 
Renal Biopsy-WPS Office.ppt
Renal  Biopsy-WPS Office.pptRenal  Biopsy-WPS Office.ppt
Renal Biopsy-WPS Office.ppt
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Management of penetrating renal injury
Management of penetrating renal injury Management of penetrating renal injury
Management of penetrating renal injury
 
early care post kidney trasplantation .
early care post kidney trasplantation . early care post kidney trasplantation .
early care post kidney trasplantation .
 
Lower Gastrointestinal Bleeding
Lower Gastrointestinal BleedingLower Gastrointestinal Bleeding
Lower Gastrointestinal Bleeding
 
Chronic subdural hematoma.pptx
Chronic subdural hematoma.pptxChronic subdural hematoma.pptx
Chronic subdural hematoma.pptx
 
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....
 
Wilms tumor
Wilms tumorWilms tumor
Wilms tumor
 

Dernier

LAMP PCR.pptx by Dr. Chayanika Das, Ph.D, Veterinary Microbiology
LAMP PCR.pptx by Dr. Chayanika Das, Ph.D, Veterinary MicrobiologyLAMP PCR.pptx by Dr. Chayanika Das, Ph.D, Veterinary Microbiology
LAMP PCR.pptx by Dr. Chayanika Das, Ph.D, Veterinary MicrobiologyChayanika Das
 
Harry Coumnas Thinks That Human Teleportation May Ensure Humanity's Survival
Harry Coumnas Thinks That Human Teleportation May Ensure Humanity's SurvivalHarry Coumnas Thinks That Human Teleportation May Ensure Humanity's Survival
Harry Coumnas Thinks That Human Teleportation May Ensure Humanity's Survivalkevin8smith
 
Introduction of Organ-On-A-Chip - Creative Biolabs
Introduction of Organ-On-A-Chip - Creative BiolabsIntroduction of Organ-On-A-Chip - Creative Biolabs
Introduction of Organ-On-A-Chip - Creative BiolabsCreative-Biolabs
 
Loudspeaker- direct radiating type and horn type.pptx
Loudspeaker- direct radiating type and horn type.pptxLoudspeaker- direct radiating type and horn type.pptx
Loudspeaker- direct radiating type and horn type.pptxpriyankatabhane
 
Food_safety_Management_pptx.pptx in microbiology
Food_safety_Management_pptx.pptx in microbiologyFood_safety_Management_pptx.pptx in microbiology
Food_safety_Management_pptx.pptx in microbiologyHemantThakare8
 
Understanding Nutrition, 16th Edition pdf
Understanding Nutrition, 16th Edition pdfUnderstanding Nutrition, 16th Edition pdf
Understanding Nutrition, 16th Edition pdfHabibouKarbo
 
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learning
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep LearningCombining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learning
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learningvschiavoni
 
EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer Zahana
EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer ZahanaEGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer Zahana
EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer ZahanaDr.Mahmoud Abbas
 
Observation of Gravitational Waves from the Coalescence of a 2.5–4.5 M⊙ Compa...
Observation of Gravitational Waves from the Coalescence of a 2.5–4.5 M⊙ Compa...Observation of Gravitational Waves from the Coalescence of a 2.5–4.5 M⊙ Compa...
Observation of Gravitational Waves from the Coalescence of a 2.5–4.5 M⊙ Compa...Sérgio Sacani
 
Science (Communication) and Wikipedia - Potentials and Pitfalls
Science (Communication) and Wikipedia - Potentials and PitfallsScience (Communication) and Wikipedia - Potentials and Pitfalls
Science (Communication) and Wikipedia - Potentials and PitfallsDobusch Leonhard
 
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...Christina Parmionova
 
BACTERIAL SECRETION SYSTEM by Dr. Chayanika Das
BACTERIAL SECRETION SYSTEM by Dr. Chayanika DasBACTERIAL SECRETION SYSTEM by Dr. Chayanika Das
BACTERIAL SECRETION SYSTEM by Dr. Chayanika DasChayanika Das
 
Environmental acoustics- noise criteria.pptx
Environmental acoustics- noise criteria.pptxEnvironmental acoustics- noise criteria.pptx
Environmental acoustics- noise criteria.pptxpriyankatabhane
 
DETECTION OF MUTATION BY CLB METHOD.pptx
DETECTION OF MUTATION BY CLB METHOD.pptxDETECTION OF MUTATION BY CLB METHOD.pptx
DETECTION OF MUTATION BY CLB METHOD.pptx201bo007
 
lect1 introduction.pptx microbiology ppt
lect1 introduction.pptx microbiology pptlect1 introduction.pptx microbiology ppt
lect1 introduction.pptx microbiology pptzbyb6vmmsd
 
Abnormal LFTs rate of deco and NAFLD.pptx
Abnormal LFTs rate of deco and NAFLD.pptxAbnormal LFTs rate of deco and NAFLD.pptx
Abnormal LFTs rate of deco and NAFLD.pptxzeus70441
 
Environment modelling and its environmental aspects
Environment modelling and its environmental aspectsEnvironment modelling and its environmental aspects
Environment modelling and its environmental aspectsMansi Rastogi
 

Dernier (20)

Introduction Classification Of Alkaloids
Introduction Classification Of AlkaloidsIntroduction Classification Of Alkaloids
Introduction Classification Of Alkaloids
 
LAMP PCR.pptx by Dr. Chayanika Das, Ph.D, Veterinary Microbiology
LAMP PCR.pptx by Dr. Chayanika Das, Ph.D, Veterinary MicrobiologyLAMP PCR.pptx by Dr. Chayanika Das, Ph.D, Veterinary Microbiology
LAMP PCR.pptx by Dr. Chayanika Das, Ph.D, Veterinary Microbiology
 
Harry Coumnas Thinks That Human Teleportation May Ensure Humanity's Survival
Harry Coumnas Thinks That Human Teleportation May Ensure Humanity's SurvivalHarry Coumnas Thinks That Human Teleportation May Ensure Humanity's Survival
Harry Coumnas Thinks That Human Teleportation May Ensure Humanity's Survival
 
Introduction of Organ-On-A-Chip - Creative Biolabs
Introduction of Organ-On-A-Chip - Creative BiolabsIntroduction of Organ-On-A-Chip - Creative Biolabs
Introduction of Organ-On-A-Chip - Creative Biolabs
 
Loudspeaker- direct radiating type and horn type.pptx
Loudspeaker- direct radiating type and horn type.pptxLoudspeaker- direct radiating type and horn type.pptx
Loudspeaker- direct radiating type and horn type.pptx
 
Food_safety_Management_pptx.pptx in microbiology
Food_safety_Management_pptx.pptx in microbiologyFood_safety_Management_pptx.pptx in microbiology
Food_safety_Management_pptx.pptx in microbiology
 
Understanding Nutrition, 16th Edition pdf
Understanding Nutrition, 16th Edition pdfUnderstanding Nutrition, 16th Edition pdf
Understanding Nutrition, 16th Edition pdf
 
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learning
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep LearningCombining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learning
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learning
 
EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer Zahana
EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer ZahanaEGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer Zahana
EGYPTIAN IMPRINT IN SPAIN Lecture by Dr Abeer Zahana
 
Observation of Gravitational Waves from the Coalescence of a 2.5–4.5 M⊙ Compa...
Observation of Gravitational Waves from the Coalescence of a 2.5–4.5 M⊙ Compa...Observation of Gravitational Waves from the Coalescence of a 2.5–4.5 M⊙ Compa...
Observation of Gravitational Waves from the Coalescence of a 2.5–4.5 M⊙ Compa...
 
Interferons.pptx.
Interferons.pptx.Interferons.pptx.
Interferons.pptx.
 
Science (Communication) and Wikipedia - Potentials and Pitfalls
Science (Communication) and Wikipedia - Potentials and PitfallsScience (Communication) and Wikipedia - Potentials and Pitfalls
Science (Communication) and Wikipedia - Potentials and Pitfalls
 
Bioenergetics and the role of ATP to drive the beats of life.
Bioenergetics and the role of ATP to drive the beats of life.Bioenergetics and the role of ATP to drive the beats of life.
Bioenergetics and the role of ATP to drive the beats of life.
 
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
 
BACTERIAL SECRETION SYSTEM by Dr. Chayanika Das
BACTERIAL SECRETION SYSTEM by Dr. Chayanika DasBACTERIAL SECRETION SYSTEM by Dr. Chayanika Das
BACTERIAL SECRETION SYSTEM by Dr. Chayanika Das
 
Environmental acoustics- noise criteria.pptx
Environmental acoustics- noise criteria.pptxEnvironmental acoustics- noise criteria.pptx
Environmental acoustics- noise criteria.pptx
 
DETECTION OF MUTATION BY CLB METHOD.pptx
DETECTION OF MUTATION BY CLB METHOD.pptxDETECTION OF MUTATION BY CLB METHOD.pptx
DETECTION OF MUTATION BY CLB METHOD.pptx
 
lect1 introduction.pptx microbiology ppt
lect1 introduction.pptx microbiology pptlect1 introduction.pptx microbiology ppt
lect1 introduction.pptx microbiology ppt
 
Abnormal LFTs rate of deco and NAFLD.pptx
Abnormal LFTs rate of deco and NAFLD.pptxAbnormal LFTs rate of deco and NAFLD.pptx
Abnormal LFTs rate of deco and NAFLD.pptx
 
Environment modelling and its environmental aspects
Environment modelling and its environmental aspectsEnvironment modelling and its environmental aspects
Environment modelling and its environmental aspects
 

Renal biopsy fadl

  • 1. Ahmed Ezzat Fadl Resident of Nephrology (D.M.N.I)
  • 2. 1. DEFENITION 2. History of Renal biopsy 3. Indications 4. C.I 5. Preparation for biopsy 6. Procedure 7. Post procedure 8. Complications
  • 3. Definition:-  A renal biopsy is a procedure used to obtain a segment of renal tissue, usually through a needle or another surgical instrument.
  • 4. History:-  Before 1951, the only way of obtaining kidney tissue from a live person was through an open operation.  Danish physicians Poul Iversen and Claus Brun described a method involving needle biopsy which has become the new standard.  Recent widespread availability of real-time imaging guidance using ultrasound or CT scanning having improved safety of the procedure.
  • 5.
  • 6. Is the Biopsy Necessary?  Always judge the balance of risk vs benefit  Most nephrologists would agree that renal biopsy is more likely to change management in symptomatic kidney disease  It can also be useful for prognostic purposes, as well as helping to direct or change treatment
  • 7. Indications 1) Significant proteinuria (>1g/day)/Nephrotic syndrome with two normal sized, non- obstructed, kidneys and no obvious cause (usually considering the diagnosis of a glomerulo- or interstitial nephritis) 2) Acute Kidney Injury (AKI) with two normal sized, non-obstructed, kidneys and no obvious cause (pre and post-renal causes excluded)or non resolving clinical ATN>3-4 weeks
  • 8. 3) Chronic Kidney Disease (CKD) with two normal sized, non-obstructed, kidneys and no obvious cause 4) Renal transplant dysfunction 5) Systemic disease with renal dysfunction
  • 9. Less common (and more controversial) indications. (Many of these patients may have normal renal function)  Microscopic haematuria  Familial renal disease (where diagnosis in this patient, benefits them and their family)
  • 10. Diabetes and Renal Biopsy  If the clinical presentation is consistent with diabetic nephropathy (ie ,signficant proteinuria [often nephrotic range], CKD3b- 4, diabetes of over 10 years duration, presence of other microvascular complications [eg retinopathy and neuropathy]) biopsy is not necessary and it can be assumed that the patient has diabetic nephropathy (THE NEW TERM DKD) why!  When to biopsy diabetic patient : 1) Microscopic hematuria 2) Absence of retinopathy and neuropathy 3) Onset of significant proteinuria <5 years from diagnosis 4) Acute worsening of renal function 5) Systemic features
  • 11.  Pediatric age group:  Sedation is used (ketamine, midazolam, promethazine, BZDs)  18-G gun is used  Pregnancy: Indications of biopsy  Sudden unexplained deterioration of renal function before 30-32 weeks POG  Symptomatic N.S before 30-32 weeks POG  Active urinary sediments, proteinuria and borderline renal function renal biopsy in pregnancy is safe before 30 weeks of pregnancy.
  • 12. Transplanted kidney  Biopsy is performed from the transplanted kidney to exclude rejection, BK nephropathy, drug-toxicity or recurrence of the disease that caused kidney failure  For surveillance of hidden disease involving the transplant kidney, so-called protocol renal biopsy undertaken at fixed intervals post-transplantation.
  • 13. Age, Race and Renal Biopsy  Moutzouris (2009) has published a series of biopsies in the elderly (> 80 years) suggesting that this is still a useful technique with results that affect management in a significant number of patients.  There are racial differences between biopsy appearances. For example, Hoy (2012) has described a wide range of atypical findings in Australian aborginal people.
  • 14.
  • 16. 1) Uncorrectable bleeding diathesis 2) Uncontrollable severe hypertension (>160/95) 3) Active renal or perirenal infection 4) Skin infection at biopsy site 5) Presence of a solitary native kidney(except in …… ) 6) Renal neoplasm, multiple cysts, abscess or pyelonephritis
  • 17. 1) Certain anatomical abnormalities of the kidney (eg vascular lesion) 2) Medications that interfere with clotting (e.g. warfarin or heparin) 3) Pregnancy(safe before 30 w) 4) Uncooperative patient (some consider absolute C.I)
  • 18. Prior to the procedure  Informed consent is usually taken.  Arrangements will also be made to ensure that appropriate post-biopsy care and supervision is in place  The patient has the right to consent or decline
  • 19.
  • 21.  NSAIDs should be stopped 24 hours before procedure.  For elective biopsies, anti-platelet agents (aspirin &clopidogrel) should be stopped 7 days before the biopsy.  Warfarin should ideally be stopped 7 days before the procedure and the patient converted to heparin if clinically indicated.  Heparin (including prophylactic and LMW) should be stopped at least 24 hours pre-procedure.  Ideally anticoagulation should not be restarted for 1 week post- biopsy.  If clinically indicated anticoagulation can be started after 24 hours, but this should be delayed further if there is macroscopic haematuria or a drop in haemoglobin.
  • 22. Biopsy gun :  14 G guns gives greater number of glomeruli per core than 18-G cores, but the rates of adequate biopsies were similar  Larger needle provided more tissue and glomeruli but were associated with more pain.  16-gauge needles are used as a compromise between the need of a sufficient size of tissue and the need of clinical safety.
  • 23.
  • 24.
  • 25.  Biopsy sample is divided and sent off for: light microscopy , Immunoflourescence and Electron microscopy
  • 26.
  • 27.
  • 28.
  • 29. Procedure  Patient in prone position with wedge or pillow below the abdomen  Light sedation  Local anesthesia with 1-2% lignocaine subcutaneous  Stab incision can be given to ease biopsy gun entry  Advance the biopsy gun, when the capsule is reached, instruct patient to take a deep breath and fire the gun  2-3 cores can be taken from the lower pole of the left kidney & placed in 10ml of normal saline 0.9% and taken to the laboratory.  Press on wound for 2-5 minutes
  • 30.  Renal biopsy is typically performed by a nephrologist or interventional radiologist
  • 31.
  • 32. Post procedure  Bed rest flat on back(≈4 hr) is instructed  BP and pulse are monitored in the following way:- Every 15 mins for 1 hour Every 30 mins for 1 hour Every hour for 4 hours  4 hourly for next remaining 24 hours  Save each voided urine sample in clear specimen container  CBC & Hct monitored 6-8 hours and 18-24 hours after biopsy
  • 33. omplicationsC 1) Bleeding 2) AV fistula - these are common and can be demonstrated by angiography in 10-20% of patients. Such lesions are usually clinically silent, and more than 95% resolve spontaneously within 2 years. In rare instances, embolisation or surgical correction of the fistula is required because of severe hypertension, persistent hematuria, congestive heart failure, or hydronephrosis 3) Aneurysm - these occur in less than 1% of patients and the majority resolve spontaneously Rarely they can lead to significant ischaemic problems and may require
  • 34. omplicationsCCont. 4) Biopsy of other organs (spleen, liver, pancreas, bowel, gall bladder) 5) Calyceal-peritoneal fistula 6) Dispersion of carcinoma 7) 'Page kidney' - compression of the kidney by peri-renal haematoma leading to renin-mediated hypertension
  • 35. There is also an approximately 5% chance of obtaining an inadequate tissue sample. In other words, from the patients' perspective, the most important common complication of biopsy is having to do it agaaaaaain  
  • 36. Haemorrhage The major complication of renal biopsy is bleeding. A degree of peri-renal bleeding post-biopsy is inevitable and the mean fall in haemoglobin after a renal biopsy is 1 g/dL  Bleeds are usually small and self-limiting and manifest as:  Peri-renal haematoma (Manno, 2004). Peri-renal haematomas are common, and usually self limiting..  Non-visible haematuria (35%).  Visible haematuria (3%).
  • 37. of a major bleedanagementM  Tachycardia may be the first sign of bleeding – take it seriously  Classic signs of shock and back pain may happen much later  If shock develops call your blood bank and X-match 2 (or more) units of blood  Ensure the patient has good (wide bore) IV access, replace volume loss with IV saline/colloid in the first instance  Arrange an urgent ultrasound to see if there is any bleed around the kidney (peri-renal haematoma). A CT angiogram can be useful to identify both a peri-renal haematoma and also the presence and site of active bleeding  Occassionally heavy haematuria may cause clot colic or acute urinary retention  Prolonged or severe bleeding may require angiography and coil embolisation. It is sensible to inform the urologists at this stage - if angiography and embolisation fail to stop the bleeding.Nephrectomy will be required
  • 38. Discharge & follow up  Warn the patient they will feel sore around the biopsy site for 3-4 days. Patients should be given clear (written) instructions regarding pain and haematuria before they go home. These should include 24 hour contact numbers in case of complications that arise after discharge.  All patients who have had a renal biopsy should be seen in clinic soon after discharge:  Transplant biopsy: 1-2 days  Native biopsy: 2 weeks